Literature DB >> 30114638

RETRACTED: Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis.

Chunmei Hu1, Shu Liu2, Mei Han2, Yingxue Wang3, Chunling Xu4.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and the authors. Figure 2D appears similar to Figure 2D of the article that Dongkai Zhao, Zhiyu Jiang, Zhihui Wang and Jinliang Gao have previously published in Biomedicine & Pharmacotherapy 98 (2018) 719-725 https://doi.org/10.1016/j.biopha.2017.12.114. However, the images purport to represent different experiments by separate author groups. The authors offer their apologies to the readers of the journal for any inconvenience this might have caused.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  LncRNA; Retinoblastoma; STAT3; XIST; miR-124

Mesh:

Substances:

Year:  2018        PMID: 30114638     DOI: 10.1016/j.biopha.2018.08.020

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  25 in total

1.  Long non-cording RNA XIST promoted cell proliferation and suppressed apoptosis by miR-423-5p/HMGA2 axis in diabetic nephropathy.

Authors:  Hui Chen; Yuan Guo; Xingbo Cheng
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

Review 2.  Long non-coding RNA XIST predicting advanced clinical parameters in cancer: A Meta-Analysis and case series study in a single institution.

Authors:  Changkai Deng; Xianliang Hu; Ke Wu; Juan Tan; Chao Yang
Journal:  Oncol Lett       Date:  2019-07-09       Impact factor: 2.967

3.  NEAT1 promotes retinoblastoma progression via modulating miR-124.

Authors:  Lufei Wang; Defeng Yang; Rui Tian; Hui Zhang
Journal:  J Cell Biochem       Date:  2019-04-30       Impact factor: 4.429

4.  Long non-coding RNA XIST promotes malignant behavior of epithelial ovarian cancer.

Authors:  Kun Zuo; Youhong Zhao; Yukun Zheng; Xiaoli Liu; Song Du; Qing Liu
Journal:  Onco Targets Ther       Date:  2019-09-05       Impact factor: 4.147

5.  MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN.

Authors:  Manhai Gao; Zhe Cui; Dan Zhao; Shurong Zhang; Qiang Cai
Journal:  Genes Genomics       Date:  2021-06-15       Impact factor: 1.839

Review 6.  X-Inactive-Specific Transcript: Review of Its Functions in the Carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Sepideh Dashti; Molood Farsi; Mohammad Taheri; Seyed Ali Mousavinejad
Journal:  Front Cell Dev Biol       Date:  2021-06-11

Review 7.  Biological Function of Long Non-coding RNA (LncRNA) Xist.

Authors:  Wenlun Wang; Lu Min; Xinyuan Qiu; Xiaomin Wu; Chuanyang Liu; Jiaxin Ma; Dongyi Zhang; Lingyun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 8.  MicroRNA-124: An emerging therapeutic target in cancer.

Authors:  Xinqi Jia; Xu Wang; Xiaorong Guo; Jingjing Ji; Ge Lou; Junjie Zhao; Wenjia Zhou; Mian Guo; Maomao Zhang; Chao Li; Sheng Tai; Shan Yu
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

9.  Long Non-Coding RNA TP53TG1 Upregulates SHCBP1 to Promote Retinoblastoma Progression by Sponging miR-33b.

Authors:  Hongyi Wang; Zhen Zhang; Yue Zhang; Shihai Liu; Li Li
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

10.  Long non-coding RNA TUG1 aggravates cerebral ischemia and reperfusion injury by sponging miR-493-3p/miR-410-3p.

Authors:  Jinlong Du; Wenjing Li; Bing Wang
Journal:  Open Med (Wars)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.